NCT00802620

Amniotic Membrane Associated With Conjunctival Autograft Versus Conjunctival Autograft for Recurrent Pterygia

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Federal University of São Paulo · Academic / Other
• Sex: All
• Age: 15 Years – 80 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia.

Detailed description

Patients with recurrent pterygia without symblepharon were randomly assigned to undertake pterygium excision followed by amniotic membrane associated with a small conjunctival autograft (2x3mm) or conjunctival autograft (approximately 5x8mm) alone. The patients were examined after 1, 7, 30, 90, 180 and 360 days after the surgery. Recurrence was considered as a fibrovascular ingrowth of 1.5 mm or more beyond the limbus with conjunctival drag.

Conditions

• Recurrent Pterygia

Interventions

Type	Name	Description
PROCEDURE	Conjunctival autograft versus conjunctival autograft treatment for recurrent pterygia	Amniotic membrane Conjunctival autograft Conjunctival autograft Recurrent pterygia

Timeline

• Start date: 2005-06-01
• Primary completion: 2005-06-01
• First posted: 2008-12-05
• Last updated: 2008-12-05